Hansa Medical

Jan 18, 2019

Hansa Medical Announces Appointment of Anne Säfström Lanner as Vice President, Global Human Resources

Jan 15, 2019

Hansa Medical AB Provides Regulatory Update for Imlifidase in Kidney Transplantation

Dec 20, 2018

Hansa Medical AB to Change Name to Hansa Biopharma AB

Dec 11, 2018

Bulletin from the Extraordinary General Meeting of Hansa Medical AB (publ)

Nov 21, 2018

Hansa Medical AB to Present at the Evercore ISI HealthConX Conference

Oct 26, 2018

Presentation at ASN Kidney Week 2018 Highlights Stable Renal Function at up to 24 Months Following Transplantation Enabled by Imlifidase

Sep 27, 2018

Hansa Medical Reports Positive Final Top Line Results from Two Phase 2 Studies of Imlifidase for Kidney Transplantation